| scholarly article | Q13442814 |
| P2093 | author name string | Jinfei Xu | |
| Joseph R Testa | |||
| P2860 | cites work | Identification of c- MYC as a Target of the APC Pathway | Q24310637 |
| The Dlx5 and Dlx6 homeobox genes are essential for craniofacial, axial, and appendicular skeletal development | Q24675473 | ||
| Inhibition of DLX-7 homeobox gene causes decreased expression of GATA-1 and c-myc genes and apoptosis | Q24677909 | ||
| Specification of jaw subdivisions by Dlx genes | Q28218878 | ||
| Physical mapping of the split hand/split foot locus on chromosome 7 and implication in syndromic ectrodactyly | Q28242341 | ||
| Bone morphogenetic protein-2-induced alkaline phosphatase expression is stimulated by Dlx5 and repressed by Msx2 | Q28586077 | ||
| Abnormal urethra formation in mouse models of split-hand/split-foot malformation type 1 and type 4 | Q28588793 | ||
| Reversible tumorigenesis by MYC in hematopoietic lineages | Q33874286 | ||
| c-Myc target genes involved in cell growth, apoptosis, and metabolism | Q33956988 | ||
| Chromosome-mediated alterations of the MYC gene in human cancer. | Q34778071 | ||
| Modelling Myc inhibition as a cancer therapy | Q34811008 | ||
| Deregulated homeobox gene expression in cancer: cause or consequence? | Q34932292 | ||
| The many faces of c-MYC. | Q35189740 | ||
| Detection of the c-myc oncogene product in testicular cancer | Q35992310 | ||
| Homeobox gene expression in cancer: insights from developmental regulation and deregulation | Q36274462 | ||
| Ovarian cancer: homeobox genes, autocrine/paracrine growth, and kinase signaling | Q36472003 | ||
| Dlx5 specifically regulates Runx2 type II expression by binding to homeodomain-response elements in the Runx2 distal promoter | Q38321841 | ||
| Activation of placenta-specific transcription factor distal-less homeobox 5 predicts clinical outcome in primary lung cancer patients | Q38426930 | ||
| Small-molecule c-Myc inhibitor, 10058-F4, inhibits proliferation, downregulates human telomerase reverse transcriptase and enhances chemosensitivity in human hepatocellular carcinoma cells | Q40198255 | ||
| A small-molecule c-Myc inhibitor, 10058-F4, induces cell-cycle arrest, apoptosis, and myeloid differentiation of human acute myeloid leukemia | Q40219227 | ||
| Transcriptional activation of c-myc proto-oncogene by WT1 protein | Q40529835 | ||
| Reversible lymphomagenesis in conditionally c-MYC expressing mice | Q40565007 | ||
| Suppression of Myc-induced apoptosis in beta cells exposes multiple oncogenic properties of Myc and triggers carcinogenic progression. | Q40731052 | ||
| Identification of a homeodomain binding element in the bone sialoprotein gene promoter that is required for its osteoblast-selective expression | Q40883137 | ||
| Reciprocal regulation of osteocalcin transcription by the homeodomain proteins Msx2 and Dlx5. | Q42464095 | ||
| A BMP-inducible gene, dlx5, regulates osteoblast differentiation and mesoderm induction | Q42818472 | ||
| Abnormalities of protooncogenes in non-small cell lung cancer. Correlations with tumor type and clinical characteristics. | Q45946068 | ||
| Regulatory elements that modulate expression of human c-myc | Q46101026 | ||
| A novel recurrent chromosomal inversion implicates the homeobox gene Dlx5 in T-cell lymphomas from Lck-Akt2 transgenic mice | Q46721107 | ||
| Dlx homeobox gene control of mammalian limb and craniofacial development | Q52018151 | ||
| Amplifications of both c-Ki-ras with a point mutation and c-myc in a primary pancreatic cancer and its metastatic tumors in lymph nodes. | Q52834018 | ||
| Association of amplified oncogene c-myc with an abnormally banded chromosome 8 in a human leukaemia cell line | Q54486682 | ||
| Chromosome translocation can occur on either side of the c-myc oncogene in Burkitt lymphoma cells | Q58420444 | ||
| Expressing the human genome | Q59066512 | ||
| c-myc oncogene expression in colorectal cancer | Q68933915 | ||
| Stimulation of c-myc oncogene expression associated with estrogen-induced proliferation of human breast cancer cells | Q69442688 | ||
| c-myc oncoprotein levels in bladder cancer | Q70231308 | ||
| Sustained loss of a neoplastic phenotype by brief inactivation of MYC | Q74413944 | ||
| Chromosome 8 copy numbers and the c-myc gene amplification in non-small cell lung cancer. Analysis by interphase cytogenetics | Q77786601 | ||
| FOXM1c transactivates the human c-myc promoter directly via the two TATA boxes P1 and P2 | Q80241527 | ||
| P433 | issue | 31 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cell biology | Q7141 |
| positive regulation of transcription, DNA-templated | Q14818066 | ||
| Distal-less homeobox 5 | Q21102620 | ||
| P304 | page(s) | 20593-601 | |
| P577 | publication date | 2009-07-31 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | DLX5 (distal-less homeobox 5) promotes tumor cell proliferation by transcriptionally regulating MYC | |
| P478 | volume | 284 |
| Q35623134 | Adaptation of ovarian cancer cells to the peritoneal environment: Multiple mechanisms of the developmental patterning gene HOXA9 |
| Q64059376 | Allelic Switching of , , and during Colorectal Cancer Tumorigenesis |
| Q90303714 | Analysis of genetic information from the antlers of Rangifer tarandus (reindeer) at the rapid growth stage |
| Q36214162 | Co-targeting of Akt and Myc inhibits viability of lymphoma cells from Lck-Dlx5 mice |
| Q58570118 | Comparative mRNA and miRNA transcriptome analysis of a mouse model of IGFIR-driven lung cancer |
| Q91817021 | DLX5 gene regulates the Notch signaling pathway to promote glomerulosclerosis and interstitial fibrosis in uremic rats |
| Q61851740 | Depot-specific gene expression profiles during differentiation and transdifferentiation of bovine muscle satellite cells, and differentiation of preadipocytes |
| Q46534463 | Disturbed Placental Imprinting in Preeclampsia Leads to Altered Expression of DLX5, a Human-Specific Early Trophoblast Marker |
| Q31041624 | Dlx5 Homeodomain:DNA Complex: Structure, Binding and Effect of Mutations Related to Split Hand and Foot Malformation Syndrome |
| Q28554645 | Early Transcriptomic Response to LDL and oxLDL in Human Vascular Smooth Muscle Cells |
| Q34055794 | Exome sequencing reveals a heterozygous DLX5 mutation in a Chinese family with autosomal-dominant split-hand/foot malformation. |
| Q35690891 | Expression of long non-coding RNA DLX6-AS1 in lung adenocarcinoma |
| Q33596707 | GSK690693 delays tumor onset and progression in genetically defined mouse models expressing activated Akt. |
| Q38206779 | Homeobox Gene Deregulation: Impact on the Hallmarks of Cancer |
| Q35235227 | Homeobox gene Dlx-2 is implicated in metabolic stress-induced necrosis |
| Q96167143 | Identification and validation of prognosis-related DLX5 methylation as an epigenetic driver in myeloid neoplasms |
| Q40201604 | Increased copy number of the DLX4 homeobox gene in breast axillary lymph node metastasis |
| Q100407688 | KDM4A promotes the growth of non-small cell lung cancer by mediating the expression of Myc via DLX5 through the Wnt/β-catenin signaling pathway |
| Q42314702 | The homeoprotein Dlx5 drives murine T-cell lymphomagenesis by directly transactivating Notch and upregulating Akt signaling |
| Q34287705 | Transcription Factor DLX5 As a New Target for Promising Antitumor Agents |
Search more.